Blitz Bureau
NEW DELHI: India accounted for 26 per cent of Asia‑Pacific healthcare private equity (PE) deal volume in 2024, making it the largest PE market in the region by volume, a report said on January 8. The report from Bain & Company said that the global healthcare PE deal value hit a record $191 billion in 2025. India was the largest market in the region by volume as buyout activity shifted away from China toward India, Japan, and South Korea due to the countries’ macroeconomic fundamentals, the report said.
“We are optimistic about the outlook for healthcare private equity this year, particularly given investor confidence in market fundamentals remained high in the face of headwinds last spring,” said Nirad Jain, partner at Bain & Company and co-leader of its Healthcare Private Equity team.
Investment activity in India has been concentrated in provider and related services and biopharma and related services. In the provider space, investor interest has focused on hospitals, clinics, and supporting services.
It noted healthcare buyout volumes in India fell 18 per cent year‑on‑year in 2024, compared to a nearly 49 per cent decline across Asia‑Pacific overall. The biopharma deal value rose to an estimated $80 billion in 2025 from $55 billion in 2024 globally. The volume is expected to increase nearly 20 per cent to over 130 deals, the report said.
